Two options are currently available:
Bempedoic acid (Nilemdo) 180 mg, once daily.
Bempedoic acid 180 mg / Ezetimibe 10 mg fixed-dose combination tablet (Nustendi), once daily.
Both regimens may be taken on an empty stomach or with food.